Code Waechter’s Pfizer PFE Stock Holding History

Code Waechter’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$780K	Buy	27,778 +162	+0.6%	+$4.31K	0.46%	48
2025 Q4	$688K	Buy	27,616 +5,105	+23%	+$129K	0.44%	54
2025 Q3	$552K	Buy	22,511 +1,911	+9%	+$47.2K	0.36%	59
2025 Q2	$499K	Buy	20,600 +7,374	+56%	+$172K	0.36%	63
2025 Q1	$335K	Buy	+13,226	New	+$346K	0.28%	84

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Code Waechter's PFE Position: Q1 2026 in Review

Code Waechter increased its Pfizer (PFE) stake by 0.59% in Q1 2026, buying an estimated $4.31K and bringing the position to 27,778 shares worth $780K. The position accounts for 0.46% of the portfolio, ranked #48.

Code Waechter first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Code Waechter held 27,778 shares of Pfizer worth $780K as of Q1 2026.
Code Waechter bought 162 Pfizer shares in Q1 2026, an estimated $4.31K.
Pfizer made up 0.46% of Code Waechter's portfolio in Q1 2026, its #48 holding.
Code Waechter first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Code Waechter's 13F filing for Q1 2026, filed 15 Apr 2026.